Comparison of infection risk between enzalutamide and abiraterone in patients with prostate cancer. Lee YHA, Kai Chan JS, Leung CH, Liu AQ, et al. Cancer 2024 Jul 21. doi: 10.1002/cncr.35472.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lee YHA, Kai Chan JS, Leung CH, Liu AQ, et al. Comparison of infection risk between enzalutamide and abiraterone in patients with prostate cancer. Cancer 2024 Jul 21. doi: 10.1002/cncr.35472.
PMID: 39033495